Gynecology

Contemporary OB/GYN Senior Editor Angie DeRosa sat down with Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, to discuss gynecologic care considerations for transmasculine people.

Find additional resources for providing high-quality sexual and reproductive healthcare to transmasculine people, transgender men, and nonbinary people, whose sex assigned at birth was female.

Based on the literature, a bundled intervention was created that included dual antibiotic prophylaxis (cefazolin and metronidazole) aimed at reducing surgical site infections for all patients undergoing hysterectomy.

There are several steps clinics can take to create a safe, supportive, and welcoming environment for transgender and nonbinary people. Is your hospital and/or practice one of them?

Training gynecologic oncologists to perform cytoreduction for advanced ovarian cancer can result in better outcomes for patients, according to results of a new study

Transgender and nonbinary people face disproportionate rates of stigma and discrimination in seeking healthcare—and may encounter additional unique barriers in attaining gynecologic and reproductive care.

Transgender and nonbinary people face discrimination and stigma, along with other barriers, in accessing health care.

This clinical consensus statement on vaginal energy-based devices (EBDs) reflects statements drafted by content experts from the American Urogynecologic Society’s (AUGS) EBD writing group.

“In the past 55 years since I became a physician, progress has been made but we still have so much more to do and a long way to go.”

Senior Editor Angie DeRosa and Associate Editor Lindsey Carr sat down with Drs. Vanessa Rogers and Shawna Nesbitt to discuss racism and unconscious bias in ob/gyn practice.

The American Academy of Pediatrics has released new information to improve long-acting reversible contraception (LARC) access for teenagers.

This Thursday, July 30, 2020 at 6 p.m. EDT, join us for a 1-hour live webinar as experts in infectious disease, virology, and vaccinology break down the top vaccine candidates, key findings from the latest clinical trials, and discuss ways to overcome the logistical hurdles of a vaccine rollout amid a global pandemic.

Postmenopausal women who breastfed for at least 6 months cumulatively have a significantly lower incidence of subclinical atherosclerosis compared to postmenopausal women who breastfeed for a shorter duration, according to a cross-sectional study in the journal Gynecological Endocrinology.

The study found that both patient- and treatment-related factors contributed to noncompliance.

Contemporary OB/GYN Senior Editor Angie DeRosa interviews Maternal-Fetal Medicine Specialist Dr. Washington Hill to get his perspective on what practicing ob/gyns can do to address implicit bias and racism in the health care system.

The National Institutes of Health (NIH) will host a virtual panel discussion on Wednesday, July 22, 2020 from 2 p.m. to 3 p.m. EST.

New research suggests levonorgestrel IUDs are successful in treating adolescents with HMB and AUB.

The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.

Results of a nationally representative study indicate that many young women receive bimanual pelvic exams (BPEs) and Pap tests that may be unnecessary, and not in compliance with the latest guidance from the American College of Obstetricians and Gynecologists (ACOG).

Nearly two-thirds of women newly diagnosed with endometriosis filled an opioid prescription within the first year, according to a US population-based claims study.

Bridging the generational gap in the physician workforce.

The American Urogynecologic Society (AUGS) released new information on managing mesh problems, which includes guidance, treatment algorithms and ways to optimize treatment outcomes for these complications.

With virtual scribes, your practice could reduce physician workload and increase revenue. Read more for details from Medical Economics’ insightful article.

Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.

The first study to characterize endometriosis in transmasculine individuals has concluded that evaluation for endometriosis with dysmenorrhea is limited in this unique population